The Value of Genetic Testing
- Genetic testing can empower women with valuable information about ovarian cancer risk and treatment
- Certain gene mutations, such as BRCA 1 and BRCA 2, can significantly increase a woman’s ovarian cancer risk
- In cases where a woman tests positive for a BRCA gene mutation, she might consider preventative measures, such as surgery to remove her ovaries and uterus
However genetic testing for ovarian cancer can lead to life-saving actions and screening tests for early detection. And when it comes to ovarian cancer, which is curable in over 90 percent of cases when diagnosed early enough, genetic testing can be a valuable option.
Read MoreIn cases where someone does test positive for a BRCA gene mutation, Lauren Mills, a genetic counselor at UT Health San Antonio says that she may be advised to undergo surgery to remove both of her ovaries and her uterus to eliminate her risk of ovarian cancer.
“The recommendation is to get a bilateral oophorectomy and hysterectomy, so getting the ovaries and the uterus removed,” Mills explains, adding that procedure is ideally done after childbearing years, usually between ages of 40 to 45.
Of course, not every woman will elect to have this preventative (or “prophylactic,” as doctors tend to call it) surgery. This is an individual choice, and in cases where a woman does not choose surgery, there are other ways to stay on top of ovarian cancer risks, such as undergoing a CA 125 blood test or receiving a transvaginal ultrasound. Ultimately, however, it is important to note that these tests are not foolproof; they don’t necessarily pick up every ovarian cancer, which is part of the reason why ovarian cancer is often diagnosed at a late stage.
Learn more about SurvivorNet's rigorous medical review process.